While much of the public focus remains on dramatic physical transformations and improved cardiovascular outcomes, the internet has started buzzing about a quirky new side effect: Ozempic Teeth
Selective GHSR-1a agonist pentapeptide
Retinal Disorders in Patients with Type 2 Diabetes In a trial of adult patients with type 2 diabetes and BMI greater than or equal to 27 kg/m 2 for weight reduction, retinal disorders were reported by 6.9% of patients treated with WEGOVY (semaglutide 2.4 mg), 6.2% of patients treated with semaglutide 1 mg, and 4.2% of patients treated with placebo
Injection-site reactions: Redness, mild swelling, or itching at the sermorelin injection site
Users are buying specialized products to combat reduced calorie intake, which include protein shakes, hydration solutions, and even micronutrient supplements to avoid lean muscle loss